Get startedLog in
    Picture of Maat Pharma SA logo

    MAAT — Maat Pharma SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: MaaT Pharma Signs Licensing, Commercial Supply Agreement With Clinigen for Xervyteg Medicine

    Picture of Maat Pharma SA logoMaat Pharma SA
    02/07/2025 19:16
    July 2 (Reuters) - MaaT Pharma SA MAAT.PA:

MAAT PHARMA ANNOUNCES EXCLUSIVE COMMERCIALIZATION PARTNERSHIP WITH CLINIGEN FOR XERVYTEG® IN ACUTE GRAFT-VERSUS HOST DISEASE IN EUROPE

MAAT PHARMA SA - TO RECEIVE €10.5 MILLION UPFRONT PAYMENT

MAAT PHARMA SA - ELIGIBLE FOR UP TO €18 MILLION IN MILESTONES

Source text: ID:nBwg0Yz5a

Further company coverage: MAAT.PA

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Maat Pharma SA

    See all news